Form 4: Astrana Health Officer, Dinesh M. Kumar, Reports Acquisition of Restricted Stock

Dinesh M. Kumar, Chief Medical Officer of Astrana Health Enablement of Nevada, reports the acquisition of 67,238 shares of restricted common stock and holdings of 216,839 shares.

Summary

• Dinesh M. Kumar, Chief Medical Officer of Astrana Health Enablement of Nevada, filed a Form 4 detailing changes in beneficial ownership of Astrana Health, Inc. stock.
• On November 8, 2024, Kumar acquired 67,238 shares of restricted common stock under the Issuer's 2024 Equity Incentive Plan, subject to performance goals and continued employment.
• The reported transaction brings Kumar's total holdings to 216,839 shares, including 214,370 shares of restricted stock vesting in installments starting January 1, 2025, and January 23, 2025, also subject to performance goals.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects standard executive compensation practices and alignment of interests with company performance.

Positives

• The acquisition of restricted stock aligns Kumar's interests with the company's performance.
• The vesting schedule encourages long-term commitment and achievement of performance goals.

Risks

• The vesting of the restricted stock is contingent on Kumar's continued employment with the Issuer.
• The vesting of a portion of the restricted stock is dependent on the achievement of certain performance goals, which may not be met.

Future Outlook

The vesting of the restricted stock is tied to performance goals, suggesting a focus on future company performance.

Industry Context

This filing is a routine disclosure related to executive compensation and equity ownership, common in publicly traded companies.

Stakeholder Impact

• Shareholders may view the equity grant as a positive sign, aligning management's interests with company performance.
• Employees may be motivated by the presence of equity incentives for key executives.

Key Dates